The short answer
BPC-157 corresponds to a fifteen-residue partial sequence of body protection compound, a protein reported in human gastric juice. The synthetic peptide is not isolated from the stomach. It is made by solid-phase synthesis from a sequence found there.
Key facts
- Source protein
- Body protection compound
- Found in
- Human gastric juice
- BPC-157
- A 15-residue partial sequence
- Production
- Solid-phase synthesis
- Not
- Extracted from gastric juice
- Reported property
- Stability in gastric juice
What was found where
The Zagreb group reported a protein in human gastric juice which they named body protection compound. BPC-157 is a fifteen-residue stretch of that protein's sequence, synthesised independently. The distinction matters: the peptide sold and studied is a synthetic construct, not a purified natural product.
Why gastric juice is an interesting place to look
It is one of the most chemically aggressive environments in the body: strongly acidic and rich in pepsin. Anything surviving there has properties worth understanding, and the stomach lining's ability to withstand its own secretions is a real physiological question. Looking for protective factors in that fluid is a reasonable research strategy.
Research material referenced
BPC-157 5mg, third-party HPLC tested
The stability claim this origin supports
The compound is routinely described as stable in human gastric juice, which is the specific property its name and its literature emphasise. Most peptides are destroyed there within minutes. If BPC-157 resists that, its proline content is a plausible structural explanation, since proline-adjacent bonds are poor substrates for most proteases including pepsin.
What a fragment relationship does not establish
That the fifteen-residue peptide does what the parent protein does. This is the same caution that applies to TB-500 and thymosin beta-4: a fragment is a different molecule, and activity of the parent does not transfer automatically. Here the parent protein is much less characterised than thymosin beta-4, so the comparison is harder to make in either direction.
Reading the origin claim carefully
Endogenous origin is frequently deployed as an argument for safety or naturalness. It establishes neither. A sequence occurring in a protein somewhere in the body says nothing about what happens when a fragment of it is synthesised and administered at a chosen concentration by a chosen route.
Frequently asked questions
Is BPC-157 extracted from gastric juice?
No. It is synthesised. The sequence corresponds to part of a protein reported in gastric juice.
Is BPC-157 naturally occurring?
The sequence occurs within a larger protein. The fifteen-residue peptide as such is a synthetic construct.
Does the origin make it safe?
No. Endogenous origin of a sequence says nothing about what a synthetic fragment does when administered.
Continue researching
Peer-reviewed guides, comparators and matched reference materials.
Primary sources & clinical trials
Peer-reviewed research and registered trials from PubMed, ClinicalTrials.gov, PubChem, FDA and NIH. All links open in a new tab and point to the primary source, so every claim can be verified at origin.
- PubMedSikiric P et al., Stable gastric pentadecapeptide BPC 157. Curr Pharm Des 2011 (PMID 21548867)pubmed.ncbi.nlm.nih.gov
- PubMedSikiric P et al. Pharmaceuticals (Basel) 2023 (PMID 37513963)pubmed.ncbi.nlm.nih.gov
- PubChemPubChem · BPC-157 (CID 9941957)pubchem.ncbi.nlm.nih.gov
- PubMedSikiric P et al., Fistulas Healing: Stable Gastric Pentadecapeptide BPC 157 Therapy. Curr Pharm Des 2020 (PMID 32329684)pubmed.ncbi.nlm.nih.gov
- PubMedKrivic A et al., Achilles detachment in rat and stable gastric pentadecapeptide BPC 157. J Orthop Res 2006 (PMID 16583442)pubmed.ncbi.nlm.nih.gov
- PubMedCerovecki T et al., Pentadecapeptide BPC 157 improves ligament healing in the rat. J Orthop Res 2010 (PMID 20225319)pubmed.ncbi.nlm.nih.gov
- PubMedSeiwerth S et al., BPC 157 and blood vessels. Curr Pharm Des 2014 (PMID 23782145)pubmed.ncbi.nlm.nih.gov
- GuidelineGoogle: Creating helpful, reliable, people-first contentdevelopers.google.com
Browse the wider literature
Live database searches, not fixed citations. Results change as new work is indexed.
Written and reviewed by
William Heath · Editor, UK Peptides research library
William Heath edits the UK Peptides research library. He is responsible for what is published here: every article is sourced to primary literature, every purity or identity statement traces to a signed third-party certificate for a specific lot, and corrections are made in place with the review date updated. No scientific or medical credentials are claimed on this site; the evidence is carried by the cited sources and the certificates, not by the byline.
More BPC-157 (Pentadecapeptide) articles
- The Stability Claim, ExaminedThe literature calls it the stable gastric pentadecapeptide. What stability means here, what supports the claim, and what it does not imply.
- BPC-157 Storage, Stability and ReconstitutionProline-rich and free of cysteine and methionine, so enzymatically and chemically robust. Why gastric stability does not remove the need for cold, dry storage.
- BPC-157 Mechanism: Why It Is Described as Multi-PathwayReported effects span angiogenic signalling, growth-factor interactions and nitric oxide pathways. Why no single defining mechanism has emerged.
- BPC-157 and Blood VesselsVascular effects recur across the BPC-157 literature and offer the most plausible common thread linking its reported activity in different tissues.
- Tendon and Ligament ModelsKrivic on Achilles detachment and Cerovecki on ligament healing, both in the Journal of Orthopaedic Research. What rat models can and cannot establish.